Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer
•Chemotherapy induces microbiome disruption, inflammation, and cognitive decline.•The resulting microbiome disruption relates to cognitive decline and inflammation.•Those cognitively impaired have unique chemotherapy-induced microbiome alterations. Chemotherapy is notorious for causing behavioral si...
Saved in:
| Published in | Brain, behavior, and immunity Vol. 120; pp. 208 - 220 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Inc
01.08.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | •Chemotherapy induces microbiome disruption, inflammation, and cognitive decline.•The resulting microbiome disruption relates to cognitive decline and inflammation.•Those cognitively impaired have unique chemotherapy-induced microbiome alterations.
Chemotherapy is notorious for causing behavioral side effects (e.g., cognitive decline). Notably, the gut microbiome has recently been reported to communicate with the brain to affect behavior, including cognition. Thus, the aim of this clinical longitudinal observational study was to determine whether chemotherapy-induced disruption of the gut microbial community structure relates to cognitive decline and circulating inflammatory signals. Fecal samples, blood, and cognitive measures were collected from 77 patients with breast cancer before, during, and after chemotherapy. Chemotherapy altered the gut microbiome community structure and increased circulating TNF-α. Both the chemotherapy-induced changes in microbial relative abundance and decreased microbial diversity were related to elevated circulating pro-inflammatory cytokines TNF-α and IL-6. Participants reported subjective cognitive decline during chemotherapy, which was not related to changes in the gut microbiome or inflammatory markers. In contrast, a decrease in overall objective cognition was related to a decrease in microbial diversity, independent of circulating cytokines. Stratification of subjects, via a reliable change index based on 4 objective cognitive tests, identified objective cognitive decline in 35% of the subjects. Based on a differential microbial abundance analysis, those characterized by cognitive decline had unique taxonomic shifts (Faecalibacterium, Bacteroides, Fusicatenibacter, Erysipelotrichaceae UCG-003, and Subdoligranulum) over chemotherapy treatment compared to those without cognitive decline. Taken together, gut microbiome change was associated with cognitive decline during chemotherapy, independent of chemotherapy-induced inflammation. These results suggest that microbiome-related strategies may be useful for predicting and preventing behavioral side effects of chemotherapy. |
|---|---|
| AbstractList | Chemotherapy is notorious for causing behavioral side effects (e.g., cognitive decline). Notably, the gut microbiome has recently been reported to communicate with the brain to affect behavior, including cognition. Thus, the aim of this clinical longitudinal observational study was to determine whether chemotherapy-induced disruption of the gut microbial community structure relates to cognitive decline and circulating inflammatory signals. Fecal samples, blood, and cognitive measures were collected from 77 patients with breast cancer before, during, and after chemotherapy. Chemotherapy altered the gut microbiome community structure and increased circulating TNF-α. Both the chemotherapy-induced changes in microbial relative abundance and decreased microbial diversity were related to elevated circulating pro-inflammatory cytokines TNF-α and IL-6. Participants reported subjective cognitive decline during chemotherapy, which was not related to changes in the gut microbiome or inflammatory markers. In contrast, a decrease in overall objective cognition was related to a decrease in microbial diversity, independent of circulating cytokines. Stratification of subjects, via a reliable change index based on 4 objective cognitive tests, identified objective cognitive decline in 35% of the subjects. Based on a differential microbial abundance analysis, those characterized by cognitive decline had unique taxonomic shifts (Faecalibacterium, Bacteroides, Fusicatenibacter, Erysipelotrichaceae UCG-003, and Subdoligranulum) over chemotherapy treatment compared to those without cognitive decline. Taken together, gut microbiome change was associated with cognitive decline during chemotherapy, independent of chemotherapy-induced inflammation. These results suggest that microbiome-related strategies may be useful for predicting and preventing behavioral side effects of chemotherapy. •Chemotherapy induces microbiome disruption, inflammation, and cognitive decline.•The resulting microbiome disruption relates to cognitive decline and inflammation.•Those cognitively impaired have unique chemotherapy-induced microbiome alterations. Chemotherapy is notorious for causing behavioral side effects (e.g., cognitive decline). Notably, the gut microbiome has recently been reported to communicate with the brain to affect behavior, including cognition. Thus, the aim of this clinical longitudinal observational study was to determine whether chemotherapy-induced disruption of the gut microbial community structure relates to cognitive decline and circulating inflammatory signals. Fecal samples, blood, and cognitive measures were collected from 77 patients with breast cancer before, during, and after chemotherapy. Chemotherapy altered the gut microbiome community structure and increased circulating TNF-α. Both the chemotherapy-induced changes in microbial relative abundance and decreased microbial diversity were related to elevated circulating pro-inflammatory cytokines TNF-α and IL-6. Participants reported subjective cognitive decline during chemotherapy, which was not related to changes in the gut microbiome or inflammatory markers. In contrast, a decrease in overall objective cognition was related to a decrease in microbial diversity, independent of circulating cytokines. Stratification of subjects, via a reliable change index based on 4 objective cognitive tests, identified objective cognitive decline in 35% of the subjects. Based on a differential microbial abundance analysis, those characterized by cognitive decline had unique taxonomic shifts (Faecalibacterium, Bacteroides, Fusicatenibacter, Erysipelotrichaceae UCG-003, and Subdoligranulum) over chemotherapy treatment compared to those without cognitive decline. Taken together, gut microbiome change was associated with cognitive decline during chemotherapy, independent of chemotherapy-induced inflammation. These results suggest that microbiome-related strategies may be useful for predicting and preventing behavioral side effects of chemotherapy. Chemotherapy is notorious for causing behavioral side effects (e.g., cognitive decline). Notably, the gut microbiome has recently been reported to communicate with the brain to affect behavior, including cognition. Thus, the aim of this clinical longitudinal observational study was to determine whether chemotherapy-induced disruption of the gut microbial community structure relates to cognitive decline and circulating inflammatory signals. Fecal samples, blood, and cognitive measures were collected from 77 patients with breast cancer before, during, and after chemotherapy. Chemotherapy altered the gut microbiome community structure and increased circulating TNF-α. Both the chemotherapy-induced changes in microbial relative abundance and decreased microbial diversity were related to elevated circulating pro-inflammatory cytokines TNF-α and IL-6. Participants reported subjective cognitive decline during chemotherapy, which was not related to changes in the gut microbiome or inflammatory markers. In contrast, a decrease in overall objective cognition was related to a decrease in microbial diversity, independent of circulating cytokines. Stratification of subjects, via a reliable change index based on 4 objective cognitive tests, identified objective cognitive decline in 35% of the subjects. Based on a differential microbial abundance analysis, those characterized by cognitive decline had unique taxonomic shifts (Faecalibacterium, Bacteroides, Fusicatenibacter, Erysipelotrichaceae UCG-003, and Subdoligranulum) over chemotherapy treatment compared to those without cognitive decline. Taken together, gut microbiome change was associated with cognitive decline during chemotherapy, independent of chemotherapy-induced inflammation. These results suggest that microbiome-related strategies may be useful for predicting and preventing behavioral side effects of chemotherapy.Chemotherapy is notorious for causing behavioral side effects (e.g., cognitive decline). Notably, the gut microbiome has recently been reported to communicate with the brain to affect behavior, including cognition. Thus, the aim of this clinical longitudinal observational study was to determine whether chemotherapy-induced disruption of the gut microbial community structure relates to cognitive decline and circulating inflammatory signals. Fecal samples, blood, and cognitive measures were collected from 77 patients with breast cancer before, during, and after chemotherapy. Chemotherapy altered the gut microbiome community structure and increased circulating TNF-α. Both the chemotherapy-induced changes in microbial relative abundance and decreased microbial diversity were related to elevated circulating pro-inflammatory cytokines TNF-α and IL-6. Participants reported subjective cognitive decline during chemotherapy, which was not related to changes in the gut microbiome or inflammatory markers. In contrast, a decrease in overall objective cognition was related to a decrease in microbial diversity, independent of circulating cytokines. Stratification of subjects, via a reliable change index based on 4 objective cognitive tests, identified objective cognitive decline in 35% of the subjects. Based on a differential microbial abundance analysis, those characterized by cognitive decline had unique taxonomic shifts (Faecalibacterium, Bacteroides, Fusicatenibacter, Erysipelotrichaceae UCG-003, and Subdoligranulum) over chemotherapy treatment compared to those without cognitive decline. Taken together, gut microbiome change was associated with cognitive decline during chemotherapy, independent of chemotherapy-induced inflammation. These results suggest that microbiome-related strategies may be useful for predicting and preventing behavioral side effects of chemotherapy. |
| Author | Dawson, E. Andridge, R.R. Otto-Dobos, L.D. Williams, N.O. Strehle, L.D. Loman, B.R. Adarkwah Yiadom, S. Pyter, L.M. Grant, C.V. Gatti-Mays, M.E. Sudheendra, P.K. Wilcox, O.R. Stover, D.G. Lahoud, A.A. Wesolowski, R. Russart, K.L.G. Seng, M.M. Bailey, M.T. Halloy, N.R. Sardesai, S.D. Kiecolt-Glaser, J.K. Carpenter, K.M. |
| Author_xml | – sequence: 1 givenname: L.D. orcidid: 0000-0001-5793-3395 surname: Otto-Dobos fullname: Otto-Dobos, L.D. organization: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA – sequence: 2 givenname: C.V. surname: Grant fullname: Grant, C.V. organization: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA – sequence: 3 givenname: A.A. surname: Lahoud fullname: Lahoud, A.A. organization: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA – sequence: 4 givenname: O.R. surname: Wilcox fullname: Wilcox, O.R. organization: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA – sequence: 5 givenname: L.D. surname: Strehle fullname: Strehle, L.D. organization: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA – sequence: 6 givenname: B.R. surname: Loman fullname: Loman, B.R. organization: Center for Microbial Pathogenesis and the Oral and Gastrointestinal Microbiology Research Affinity Group, The Research Institute at Nationwide Children’s Hospital, Columbus, OH, USA – sequence: 7 givenname: S. surname: Adarkwah Yiadom fullname: Adarkwah Yiadom, S. organization: Division of Biostatistics, The Ohio State University, Columbus, OH, USA – sequence: 8 givenname: M.M. surname: Seng fullname: Seng, M.M. organization: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA – sequence: 9 givenname: N.R. surname: Halloy fullname: Halloy, N.R. organization: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA – sequence: 10 givenname: K.L.G. surname: Russart fullname: Russart, K.L.G. organization: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA – sequence: 11 givenname: K.M. surname: Carpenter fullname: Carpenter, K.M. organization: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA – sequence: 12 givenname: E. surname: Dawson fullname: Dawson, E. organization: Department of Neurology, The Ohio State University, Columbus, OH, USA – sequence: 13 givenname: S.D. surname: Sardesai fullname: Sardesai, S.D. organization: Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA – sequence: 14 givenname: N.O. surname: Williams fullname: Williams, N.O. organization: Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA – sequence: 15 givenname: M.E. surname: Gatti-Mays fullname: Gatti-Mays, M.E. organization: Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA – sequence: 16 givenname: D.G. surname: Stover fullname: Stover, D.G. organization: Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA – sequence: 17 givenname: P.K. surname: Sudheendra fullname: Sudheendra, P.K. organization: Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA – sequence: 18 givenname: R. surname: Wesolowski fullname: Wesolowski, R. organization: Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA – sequence: 19 givenname: J.K. surname: Kiecolt-Glaser fullname: Kiecolt-Glaser, J.K. organization: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA – sequence: 20 givenname: M.T. surname: Bailey fullname: Bailey, M.T. organization: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA – sequence: 21 givenname: R.R. surname: Andridge fullname: Andridge, R.R. organization: Division of Biostatistics, The Ohio State University, Columbus, OH, USA – sequence: 22 givenname: L.M. orcidid: 0000-0001-8189-0663 surname: Pyter fullname: Pyter, L.M. email: leah.pyter@osumc.com organization: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38823430$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkcFu1DAQhi1URLeFB-CCfORAwthO0lic0AoKUiUucLacyaTrJXGC7RTt2-Pttpceymk81vfN4f8v2JmfPTH2VkApQDQf92XXuVKCrEqoS1D6BdsI0FBIofQZ20Db6kLUWpyzixj3AFAr0b5i56ptpaoUbNhhu6NpTjsKdjkUzvcrUs9v18Qnh2Hu3DwR710M65Lc7D9w54fRTpM9bdb3HOdb75K7yxzh6Dxlhg802ZH4kjnyKfK_Lu14F8jGxNF6pPCavRzsGOnNw7xkv75--bn9Vtz8uP6-_XxTYAUqFbrTrUCLg1AD9k2vbZ0fVQs1DvkDG0likBVgLRAqiY2ueztI0ai6ywCqS_b-dHcJ85-VYjKTi0jjaD3NazQKGlVdSRCQ0XcP6NpN1JsluMmGg3mMKwNXJyBHE2OgwaBL91GkYN1oBJhjMWZvcjHmWIyB2uRisimemI_Hn3M-nRzK8dw5CiZiTjMX5AJhMv3snrX1E_tYjkM7_qbDf9x_It27rA |
| CitedBy_id | crossref_primary_10_1186_s12888_024_06278_x crossref_primary_10_1016_j_hoc_2024_12_005 crossref_primary_10_3390_antibiotics14030264 crossref_primary_10_1016_j_psyneuen_2025_107428 crossref_primary_10_1038_s41523_024_00707_6 crossref_primary_10_1016_j_ajpath_2024_12_013 crossref_primary_10_1158_0008_5472_CAN_24_3041 |
| Cites_doi | 10.1076/clin.12.1.43.1726 10.1016/S0887-6177(03)00039-8 10.1007/s11427-018-9456-x 10.1038/sj.cdd.4402255 10.1080/13803390490510905 10.1002/cncr.31584 10.1016/j.clbc.2019.01.006 10.1038/nrgastro.2014.66 10.1186/s40168-018-0483-7 10.3390/ijerph17207618 10.1200/JCO.2011.37.0189 10.1016/j.jneuroim.2021.577769 10.1007/s12035-020-01961-y 10.3390/nu14193959 10.1038/s41598-019-52893-0 10.1007/s40520-023-02343-9 10.1093/jncics/pkac052 10.3390/biomedicines11071789 10.1016/S1470-2045(10)70294-1 10.1080/09540261.2020.1835839 10.1371/journal.pone.0039743 10.1186/s12916-023-02751-8 10.1146/annurev-med-042320-014032 10.1016/j.cyto.2003.10.004 10.1007/s10549-023-06968-2 10.1093/neuonc/nor024 10.1037/0022-006X.59.1.12 10.1016/j.ejon.2022.102099 10.1136/bmj.m4087 10.1007/978-3-030-20301-6_9 10.2307/2533558 10.1007/s11764-017-0656-6 10.1016/j.bbi.2012.02.001 10.3390/molecules26082266 10.1200/JCO.2018.78.6624 10.1016/j.neubiorev.2020.07.002 10.1038/s41598-023-27436-3 10.1002/pon.6185 10.1038/s41598-022-05682-1 10.1002/cncr.25098 10.1155/2021/5521739 10.1016/j.bbi.2021.04.014 10.1002/pon.5028 10.1016/j.jneuroim.2016.11.002 10.3389/fonc.2021.706331 10.2144/fsoa-2020-0024 10.1038/s41467-019-10656-5 10.1038/s41598-022-23793-7 10.3390/microorganisms8101587 10.1080/1385404049052420 10.1080/13854046.2012.709886 10.1016/j.ejca.2021.11.006 10.1093/cid/ciz777 10.1016/j.cell.2014.08.006 10.1155/2005/618504 10.1111/apt.13302 10.3390/curroncol29050243 10.1200/JCO.2016.71.4410 10.1016/j.bbi.2019.02.025 10.1038/s41523-022-00455-5 10.1017/S0033291703008031 10.1093/arclin/11.4.329 10.1007/s10549-017-4240-6 10.1080/19490976.2022.2150502 10.1016/j.bbi.2019.02.020 |
| ContentType | Journal Article |
| Copyright | 2024 Elsevier Inc. Copyright © 2024 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2024 Elsevier Inc. – notice: Copyright © 2024 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.bbi.2024.05.039 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1090-2139 |
| EndPage | 220 |
| ExternalDocumentID | 38823430 10_1016_j_bbi_2024_05_039 S0889159124004392 |
| Genre | Journal Article Observational Study |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA216290 |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM 9JO AAAJQ AADFP AAEDT AAEDW AAGJA AAGUQ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXLA AAXUO AAYWO ABCQJ ABFNM ABFRF ABIVO ABJNI ABMAC ABOYX ABWVN ABXDB ACDAQ ACGFO ACGFS ACRLP ACRPL ACVFH ACXNI ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CAG CJTIS COF CS3 DM4 DU5 EBS EFBJH EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMG HMQ HVGLF HZ~ IHE J1W KOM L7B LG5 LUGTX LZ5 M2U M41 MO0 MOBAO N9A O-L O9- OAUVE OH0 OKEIE OU- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SDP SES SEW SIN SNS SPCBC SSB SSN SSY SSZ T5K TN5 UAP UNMZH UPT WUQ XPP XSW Z5R ZGI ZMT ~G- ~S- AACTN AAIAV AFCTW AFKWA AJOXV AMFUW RIG SSI AAYXX AGRNS BNPGV CITATION SSH CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c403t-9b981cacf13fcd6d9a53fc4805cffcdc62e1f240c51c042c695daf21635bffcc3 |
| IEDL.DBID | .~1 |
| ISSN | 0889-1591 1090-2139 |
| IngestDate | Thu Jul 10 21:57:29 EDT 2025 Sat Aug 30 01:59:28 EDT 2025 Thu Apr 24 23:06:41 EDT 2025 Tue Jul 01 04:10:41 EDT 2025 Sat Jul 27 15:42:30 EDT 2024 Tue Aug 26 18:39:46 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Microbial diversity Differential abundance analysis Subjective cognition Cytokines Objective cognition Cognitive impairment |
| Language | English |
| License | Copyright © 2024 Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c403t-9b981cacf13fcd6d9a53fc4805cffcdc62e1f240c51c042c695daf21635bffcc3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0001-5793-3395 0000-0001-8189-0663 |
| PMID | 38823430 |
| PQID | 3063472010 |
| PQPubID | 23479 |
| PageCount | 13 |
| ParticipantIDs | proquest_miscellaneous_3063472010 pubmed_primary_38823430 crossref_citationtrail_10_1016_j_bbi_2024_05_039 crossref_primary_10_1016_j_bbi_2024_05_039 elsevier_sciencedirect_doi_10_1016_j_bbi_2024_05_039 elsevier_clinicalkey_doi_10_1016_j_bbi_2024_05_039 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | August 2024 2024-08-00 2024-Aug 20240801 |
| PublicationDateYYYYMMDD | 2024-08-01 |
| PublicationDate_xml | – month: 08 year: 2024 text: August 2024 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Brain, behavior, and immunity |
| PublicationTitleAlternate | Brain Behav Immun |
| PublicationYear | 2024 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Chen, Liu, Ling, Tong, Xiang (b0050) 2012; 7 Dranitsaris, Maroun, Shah (b0070) 2005; 19 Zhao, Zuo, Ding, Zhang, Bi, Cheng (b0350) 2020; 12 Reitan, Wolfson (b0255) 1985 De Jager, Hogervorst, Combrinck, Budge (b0055) 2003; 33 Wefel, Vardy, Ahles, Schagen (b0335) 2011; 12 Deleemans, Chleilat, Reimer, Baydoun, Piedalue, Lowry, Henning, Carlson (b0060) 2022; 29 Montassier, Gastinne, Vangay, Al-Ghalith, Bruley des Varannes, Massart, Moreau, Potel, de La Cochetière, Batard, Knights (b0220) 2015; 42 Oh, Boyle, Pavlakis, Clarke, Guminski, Eade, Lamoury, Carroll, Morgia, Kneebone, Hruby, Stevens, Liu, Corless, Molloy, Libermann, Rosenthal, Back (b0230) 2021; 11 Zidi, Souai, Raies, Ben Ayed, Mezlini, Mezrioui, Tranchida, Sabatier, Mosbah, Cherif, Shintu, Kouidhi (b0360) 2021; 26 Liu, Mills, Rissling, Fiorentino, Natarajan, Dimsdale, Sadler, Parker, Ancoli-Israel (b0180) 2012; 26 Galloway-Peña, Shi, Peterson, Sahasrabhojane, Gopalakrishnan, Brumlow, Daver, Alfayez, Boddu, Khan, Wargo, Do, Jenq, Kontoyiannis, Shelburne (b0080) 2020; 71 Juan, Chen, Ding, Yongping, Liu, Wang, Le, Liao, Shi, Huang, Wu, Ma, Ouyang, Tong (b0150) 2022; 161 Castellon, Ganz, Bower, Petersen, Abraham, Greendale (b0035) 2004; 26 Tombaugh, Kozak, Rees (b0295) 1999; 14 Hill, Guarner, Reid, Gibson, Merenstein, Pot, Morelli, Canani, Flint, Salminen, Calder, Sanders (b0115) 2014; 11 Lyon, Cohen, Chen, Kelly, McCain, Starkweather, Ahn, Sturgill, Jackson-Cook (b0190) 2016; 301 Dhillon, Tannock, Pond, Renton, Rourke, Vardy (b0065) 2018; 12 Palm, de Zoete, Cullen, Barry, Stefanowski, Hao, Degnan, Hu, Peter, Zhang, Ruggiero, Cho, Goodman, Flavell (b0240) 2014; 158 Shrode, Knobbe, Cady, Yadav, Hoang, Cherwin, Curry, Garje, Vikas, Sugg, Phadke, Filardo, Mangalam (b0270) 2023; 13 Centers for Disease Control and Prevention, 2023. U.S. Cancer Statistics Female Breast Cancer Stat Bite [WWW Document]. US Department of Health and Human Services. Pusztai, Mendoza, Reuben, Martinez, Willey, Lara, Syed, Fritsche, Bruera, Booser, Valero, Arun, Ibrahim, Rivera, Royce, Cleeland, Hortobagyi (b0250) 2004; 25 Subramaniam, Bowen, Gladman, Lustberg, Mayo, Wardill (b0285) 2020; 116 Hatayama, Ebara, Okuma, Tokuno, Hasuko, Masuyama, Ashikari, Shirasawa (b0100) 2023; 11 Matchado, Rühlemann, Reitmeier, Kacprowski, Frost, Haller, Baumbach, List (b0210) 2024; 10 Benton, A.L., Hamsher, K., 1976. Multilingual aphasia examination (2nd ed.). AJA Associates. Hanna, T.P., King, W.D., Thibodeau, S., Jalink, M., Paulin, G.A., Harvey-Jones, E., O’Sullivan, D.E., Booth, C.M., Sullivan, R., Aggarwal, A., 2020. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ m4087. Hill, Chen, Bailey, Singh Khalsa, Maltz, Kelleher, Spees, Zhu, Loman (b0110) 2022; 14 . Rudzki, L., Maes, M., 2020. The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major Depression. Molecular Neurobiology 2020 57:10 57, 4269–4295. Wefel, Saleeba, Buzdar, Meyers (b0325) 2010; 116 Kim, Jung, Kim, Abraham (b0160) 2022; 57 Okubo, Kinoshita, Katsumata, Uezono, Xiao, Matsuoka (b0235) 2020; 85 Veal, Scott, Jim, Small (b0310) 2023; 32 Koppelmans, Breteler, Boogerd, Seynaeve, Gundy, Schagen (b0170) 2012; 30 Zhu, Ma, Wu, Xiao, Wu, Ding, Zheng, Liang, Luo, Ding, Zhao (b0355) 2022; 14 Maajani, Jalali, Alipour, Khodadost, Tohidinik, Yazdani (b0200) 2019; 19 Yoo, Groer, Dutra, Sarkar, McSkimming (b0345) 2020; 8 Bilenduke, Sterrett, Ranby, Borges, Grigsby, Carr, Kilbourn, Lowry (b0025) 2022; 12 Wefel, Cloughesy, Zazzali, Zheng, Prados, Wen, Mikkelsen, Schiff, Abrey, Yung, Paleologos, Nicholas, Jensen, Vredenburgh, Das, Friedman (b0330) 2011; 13 Wechsler (b0320) 1997 Panebianco, Andriulli, Pazienza (b0245) 2018; 6 van der Most, Currie, Robinson, Lake (b0305) 2008; 15 Levine, Miller, Becker, Selnes, Cohen (b0175) 2004; 18 Aarnoutse, Ziemons, Hillege, de Vos-Geelen, de Boer, Bisschop, Vriens, Vincent, van de Wouw, Le, Venema, Rensen, Penders, Smidt (b0005) 2022; 8 Grant, Loman, Bailey, Pyter (b0085) 2021; 95 Gullett, Cohen, Yang, Menzies, Fieo, Kelly, Starkweather, Jackson-Cook, Lyon (b0090) 2019; 28 Kong, Gao, Yan, Huang, He, Li, You, Qin (b0165) 2019; 62 Benedict, Schretlen, Groninger, Brandt (b0015) 1998; 12 Jordan, Loman, Bailey, Pyter (b0145) 2018; 124 Kenward, Roger (b0155) 1997; 53 Loman, Jordan, Haynes, Bailey, Pyter (b0185) 2019; 9 Tombaugh (b0290) 2004; 19 Janelsins, Lei, Netherby-Winslow, Kleckner, Kerns, Gilmore, Belcher, Thompson, Werner, Hopkins, Long, Cole, Culakova (b0130) 2022; 362 Ruff (b0265) 1996; 11 Vaccaro, Aglieri, Rossi, Pettinato, Ceretti, Colombo, Guaita, Rolandi (b0300) 2023; 35 Al Bander, Nitert, Mousa, Naderpoor (b0010) 2020; 17 Edwardson, D.W., Parissenti, A.M., Kovala, A.T., 2019. Chemotherapy and Inflammatory Cytokine Signalling in Cancer Cells and the Morton, Marotz, Washburne, Silverman, Zaramela, Edlund, Zengler, Knight (b0225) 2019; 10 Johnson, Silverberg, Millis, Hanks (b0140) 2012; 26 Jensen, Potosky, Moinpour, Lobo, Cella, Hahn, Thissen, Smith, Ahn, Luta, Reeve (b0135) 2017; 35 Cerulla, Arcusa, Navarro, Garolera, Enero, Chico, Fernández-Morales (b0045) 2017; 164 Whittaker, George, O’Malley (b0340) 2022; 12 Henneghan, Van Dyk, Zhou, Moore, Root, Ahles, Nakamura, Mandeblatt, Ganz (b0105) 2023; 201 Sougiannis, VanderVeen, Enos, Velazquez, Bader, Carson, Chatzistamou, Walla, Pena, Kubinak, Nagarkatti, Carson, Murphy (b0280) 2019; 80 Jacobson, Truax (b0120) 1991; 59 Lyu, Ouyang, Ma, Han, Pi, Qiu (b0195) 2021; 2021 Bower, Ganz, Irwin, Cole, Carroll, Kuhlman, Petersen, Garet, Asher, Hurvitz, Crespi (b0030) 2022; 6 Singh, Germine (b0275) 2021; 33 Janelsins, Heckler, Peppone, Ahles, Mohile, Mustian, Palesh, O’Mara, Minasian, Williams, Magnuson, Geer, Dakhil, Hopkins, Morrow (b0125) 2018; 36 Tumour Microenvironment. pp. 173–215. Walker, Joy, Vos, Stenson, Mackey, Jovel, Kao, Madsen, Wong (b0315) 2023; 21 Maldonado, Parsons, Chen, Haslam, Prasad (b0205) 2020; 6 Mayer, Nance, Chen (b0215) 2022; 73 Shrode (10.1016/j.bbi.2024.05.039_b0270) 2023; 13 Aarnoutse (10.1016/j.bbi.2024.05.039_b0005) 2022; 8 Maajani (10.1016/j.bbi.2024.05.039_b0200) 2019; 19 10.1016/j.bbi.2024.05.039_b0260 10.1016/j.bbi.2024.05.039_b0020 Jordan (10.1016/j.bbi.2024.05.039_b0145) 2018; 124 Dhillon (10.1016/j.bbi.2024.05.039_b0065) 2018; 12 Yoo (10.1016/j.bbi.2024.05.039_b0345) 2020; 8 Liu (10.1016/j.bbi.2024.05.039_b0180) 2012; 26 Wefel (10.1016/j.bbi.2024.05.039_b0330) 2011; 13 Zhao (10.1016/j.bbi.2024.05.039_b0350) 2020; 12 Walker (10.1016/j.bbi.2024.05.039_b0315) 2023; 21 Gullett (10.1016/j.bbi.2024.05.039_b0090) 2019; 28 Johnson (10.1016/j.bbi.2024.05.039_b0140) 2012; 26 Al Bander (10.1016/j.bbi.2024.05.039_b0010) 2020; 17 Hill (10.1016/j.bbi.2024.05.039_b0115) 2014; 11 Tombaugh (10.1016/j.bbi.2024.05.039_b0295) 1999; 14 Ruff (10.1016/j.bbi.2024.05.039_b0265) 1996; 11 Janelsins (10.1016/j.bbi.2024.05.039_b0130) 2022; 362 Matchado (10.1016/j.bbi.2024.05.039_b0210) 2024; 10 Singh (10.1016/j.bbi.2024.05.039_b0275) 2021; 33 Cerulla (10.1016/j.bbi.2024.05.039_b0045) 2017; 164 10.1016/j.bbi.2024.05.039_b0075 Chen (10.1016/j.bbi.2024.05.039_b0050) 2012; 7 Reitan (10.1016/j.bbi.2024.05.039_b0255) 1985 Tombaugh (10.1016/j.bbi.2024.05.039_b0290) 2004; 19 Bower (10.1016/j.bbi.2024.05.039_b0030) 2022; 6 Mayer (10.1016/j.bbi.2024.05.039_b0215) 2022; 73 Montassier (10.1016/j.bbi.2024.05.039_b0220) 2015; 42 Hill (10.1016/j.bbi.2024.05.039_b0110) 2022; 14 Levine (10.1016/j.bbi.2024.05.039_b0175) 2004; 18 Panebianco (10.1016/j.bbi.2024.05.039_b0245) 2018; 6 Hatayama (10.1016/j.bbi.2024.05.039_b0100) 2023; 11 Vaccaro (10.1016/j.bbi.2024.05.039_b0300) 2023; 35 Jacobson (10.1016/j.bbi.2024.05.039_b0120) 1991; 59 Wefel (10.1016/j.bbi.2024.05.039_b0335) 2011; 12 Dranitsaris (10.1016/j.bbi.2024.05.039_b0070) 2005; 19 Galloway-Peña (10.1016/j.bbi.2024.05.039_b0080) 2020; 71 10.1016/j.bbi.2024.05.039_b0040 Oh (10.1016/j.bbi.2024.05.039_b0230) 2021; 11 Kim (10.1016/j.bbi.2024.05.039_b0160) 2022; 57 Lyu (10.1016/j.bbi.2024.05.039_b0195) 2021; 2021 Benedict (10.1016/j.bbi.2024.05.039_b0015) 1998; 12 Loman (10.1016/j.bbi.2024.05.039_b0185) 2019; 9 Henneghan (10.1016/j.bbi.2024.05.039_b0105) 2023; 201 Jensen (10.1016/j.bbi.2024.05.039_b0135) 2017; 35 Zidi (10.1016/j.bbi.2024.05.039_b0360) 2021; 26 Wechsler (10.1016/j.bbi.2024.05.039_b0320) 1997 Koppelmans (10.1016/j.bbi.2024.05.039_b0170) 2012; 30 Bilenduke (10.1016/j.bbi.2024.05.039_b0025) 2022; 12 Subramaniam (10.1016/j.bbi.2024.05.039_b0285) 2020; 116 Sougiannis (10.1016/j.bbi.2024.05.039_b0280) 2019; 80 Kenward (10.1016/j.bbi.2024.05.039_b0155) 1997; 53 Okubo (10.1016/j.bbi.2024.05.039_b0235) 2020; 85 Castellon (10.1016/j.bbi.2024.05.039_b0035) 2004; 26 Morton (10.1016/j.bbi.2024.05.039_b0225) 2019; 10 10.1016/j.bbi.2024.05.039_b0095 van der Most (10.1016/j.bbi.2024.05.039_b0305) 2008; 15 Deleemans (10.1016/j.bbi.2024.05.039_b0060) 2022; 29 Maldonado (10.1016/j.bbi.2024.05.039_b0205) 2020; 6 Zhu (10.1016/j.bbi.2024.05.039_b0355) 2022; 14 De Jager (10.1016/j.bbi.2024.05.039_b0055) 2003; 33 Palm (10.1016/j.bbi.2024.05.039_b0240) 2014; 158 Wefel (10.1016/j.bbi.2024.05.039_b0325) 2010; 116 Pusztai (10.1016/j.bbi.2024.05.039_b0250) 2004; 25 Whittaker (10.1016/j.bbi.2024.05.039_b0340) 2022; 12 Janelsins (10.1016/j.bbi.2024.05.039_b0125) 2018; 36 Lyon (10.1016/j.bbi.2024.05.039_b0190) 2016; 301 Kong (10.1016/j.bbi.2024.05.039_b0165) 2019; 62 Grant (10.1016/j.bbi.2024.05.039_b0085) 2021; 95 Veal (10.1016/j.bbi.2024.05.039_b0310) 2023; 32 Juan (10.1016/j.bbi.2024.05.039_b0150) 2022; 161 |
| References_xml | – year: 1997 ident: b0320 article-title: WAIS-III administration and scoring manual – volume: 10 start-page: 2719 year: 2019 ident: b0225 article-title: Establishing microbial composition measurement standards with reference frames publication-title: Nat Commun – volume: 116 start-page: 470 year: 2020 end-page: 479 ident: b0285 article-title: The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment publication-title: Neurosci Biobehav Rev – volume: 35 start-page: 699 year: 2023 end-page: 710 ident: b0300 article-title: Remote testing in Abbiategrasso (RTA): results from a counterbalanced cross-over study on direct-to-home neuropsychology with older adults publication-title: Aging Clin Exp Res – volume: 12 start-page: 19547 year: 2022 ident: b0025 article-title: Impacts of breast cancer and chemotherapy on gut microbiome, cognitive functioning, and mood relative to healthy controls publication-title: Sci Rep – volume: 26 start-page: 1230 year: 2012 end-page: 1241 ident: b0140 article-title: Symptom validity indicators embedded in the controlled oral word association test publication-title: Clin Neuropsychol – volume: 6 year: 2022 ident: b0030 article-title: Acute and chronic effects of adjuvant therapy on inflammatory markers in breast cancer patients publication-title: JNCI Cancer Spectr – volume: 18 start-page: 373 year: 2004 end-page: 384 ident: b0175 article-title: Normative data for determining significance of test-retest differences on eight common neuropsychological instruments publication-title: Clin Neuropsychol – volume: 12 start-page: 43 year: 1998 end-page: 55 ident: b0015 article-title: Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest Reliability publication-title: Clin Neuropsychol – volume: 36 start-page: 3231 year: 2018 end-page: 3239 ident: b0125 article-title: Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study publication-title: Journal of Clinical Oncology – volume: 30 start-page: 1080 year: 2012 end-page: 1086 ident: b0170 article-title: Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy publication-title: Journal of Clinical Oncology – volume: 73 start-page: 439 year: 2022 end-page: 453 ident: b0215 article-title: The Gut-Brain Axis publication-title: Annu Rev Med – volume: 33 start-page: 382 year: 2021 end-page: 393 ident: b0275 article-title: Technology meets tradition: a hybrid model for implementing digital tools in neuropsychology publication-title: International Review of Psychiatry – volume: 12 start-page: 3046 year: 2020 end-page: 3056 ident: b0350 article-title: Changes in plasma IL-1β, TNF-α and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients publication-title: Am J Transl Res – volume: 2021 year: 2021 ident: b0195 article-title: Kai-Xin-San Attenuates doxorubicin-induced cognitive impairment by reducing inflammation, oxidative stress, and neural degeneration in 4T1 breast cancer mice publication-title: Evid Based Complement Alternat Med – volume: 80 start-page: 44 year: 2019 ident: b0280 article-title: Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota publication-title: Brain Behav Immun – reference: Centers for Disease Control and Prevention, 2023. U.S. Cancer Statistics Female Breast Cancer Stat Bite [WWW Document]. US Department of Health and Human Services. – volume: 6 year: 2020 ident: b0205 article-title: Estimation of US patients with cancer who may respond to cytotoxic chemotherapy publication-title: Future Sci OA – volume: 14 start-page: 3959 year: 2022 ident: b0355 article-title: Altered Gut Microbiota and Its Clinical Relevance in Mild Cognitive Impairment and Alzheimer’s Disease: Shanghai Aging Study and Shanghai Memory Study publication-title: Nutrients – volume: 12 start-page: 703 year: 2011 end-page: 708 ident: b0335 article-title: International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer publication-title: Lancet Oncol – volume: 11 start-page: 1789 year: 2023 ident: b0100 article-title: Characteristics of intestinal microbiota in japanese patients with mild cognitive impairment and a risk-estimating method for the disorder publication-title: Biomedicines – reference: Hanna, T.P., King, W.D., Thibodeau, S., Jalink, M., Paulin, G.A., Harvey-Jones, E., O’Sullivan, D.E., Booth, C.M., Sullivan, R., Aggarwal, A., 2020. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ m4087. – volume: 35 start-page: 1913 year: 2017 end-page: 1920 ident: b0135 article-title: United states population-based estimates of patient-reported outcomes measurement information system symptom and functional status reference values for individuals with cancer publication-title: Journal of Clinical Oncology – volume: 124 year: 2018 ident: b0145 article-title: Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities publication-title: Cancer – volume: 95 start-page: 401 year: 2021 end-page: 412 ident: b0085 article-title: Manipulations of the gut microbiome alter chemotherapy-induced inflammation and behavioral side effects in female mice publication-title: Brain Behav Immun – volume: 201 start-page: 139 year: 2023 end-page: 145 ident: b0105 article-title: Validating the PROMIS cognitive function short form in cancer survivors publication-title: Breast Cancer Res Treat – volume: 53 start-page: 983 year: 1997 ident: b0155 article-title: Small sample inference for fixed effects from restricted maximum likelihood publication-title: Biometrics – volume: 8 start-page: 1587 year: 2020 ident: b0345 article-title: Gut Microbiota and Immune System Interactions publication-title: Microorganisms – volume: 19 start-page: 83 year: 2005 end-page: 87 ident: b0070 article-title: Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea publication-title: Canadian Journal of Gastroenterology – volume: 42 start-page: 515 year: 2015 end-page: 528 ident: b0220 article-title: Chemotherapy-driven dysbiosis in the intestinal microbiome publication-title: Aliment Pharmacol Ther – volume: 158 start-page: 1000 year: 2014 end-page: 1010 ident: b0240 article-title: Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease publication-title: Cell – volume: 362 year: 2022 ident: b0130 article-title: Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer publication-title: J Neuroimmunol – volume: 164 start-page: 179 year: 2017 end-page: 187 ident: b0045 article-title: Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study publication-title: Breast Cancer Res Treat – volume: 25 start-page: 94 year: 2004 end-page: 102 ident: b0250 article-title: Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy publication-title: Cytokine – volume: 15 start-page: 13 year: 2008 end-page: 20 ident: b0305 article-title: Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all publication-title: Cell Death Differ – volume: 28 start-page: 997 year: 2019 end-page: 1003 ident: b0090 article-title: Relationship of fatigue with cognitive performance in women with early-stage breast cancer over 2 years publication-title: Psychooncology – volume: 14 year: 2022 ident: b0110 article-title: Facilitating a high-quality dietary pattern induces shared microbial responses linking diet quality, blood pressure, and microbial sterol metabolism in caregiver-child dyads publication-title: Gut Microbes – volume: 14 start-page: 167 year: 1999 end-page: 177 ident: b0295 article-title: Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming publication-title: Arch Clin Neuropsychol – volume: 12 start-page: 178 year: 2018 end-page: 185 ident: b0065 article-title: Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy publication-title: Journal of Cancer Survivorship – volume: 8 start-page: 89 year: 2022 ident: b0005 article-title: Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy publication-title: NPJ Breast Cancer – volume: 11 start-page: 329 year: 1996 end-page: 338 ident: b0265 article-title: Benton controlled oral word association test: Reliability and updated norms publication-title: Archives of Clinical Neuropsychology – volume: 13 start-page: 526 year: 2023 ident: b0270 article-title: Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria publication-title: Sci Rep – volume: 7 start-page: e39743 year: 2012 ident: b0050 article-title: Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer publication-title: PLoS One – volume: 71 start-page: 63 year: 2020 end-page: 71 ident: b0080 article-title: Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia publication-title: Clinical Infectious Diseases – volume: 161 start-page: 10 year: 2022 end-page: 22 ident: b0150 article-title: Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial publication-title: Eur J Cancer – volume: 59 start-page: 12 year: 1991 end-page: 19 ident: b0120 article-title: Clinical significance: A statistical approach to defining meaningful change in psychotherapy research publication-title: J Consult Clin Psychol – volume: 9 year: 2019 ident: b0185 article-title: Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice publication-title: Sci Rep – volume: 10 year: 2024 ident: b0210 article-title: On the limits of 16S rRNA gene-based metagenome prediction and functional profiling publication-title: Microb Genom – volume: 13 start-page: 660 year: 2011 end-page: 668 ident: b0330 article-title: Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab publication-title: Neuro Oncol – volume: 26 start-page: 955 year: 2004 end-page: 969 ident: b0035 article-title: Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen publication-title: J Clin Exp Neuropsychol – volume: 57 year: 2022 ident: b0160 article-title: Association of chemotherapy and subjective cognitive impairment in breast cancer patients: Meta-analysis of longitudinal prospective cohort studies publication-title: European Journal of Oncology Nursing – volume: 32 start-page: 1298 year: 2023 end-page: 1305 ident: b0310 article-title: Subjective cognition and memory lapses in the daily lives of breast cancer survivors: Examining associations with objective cognitive performance, fatigue, and depressed mood publication-title: Psychooncology – reference: Edwardson, D.W., Parissenti, A.M., Kovala, A.T., 2019. Chemotherapy and Inflammatory Cytokine Signalling in Cancer Cells and the – volume: 26 year: 2021 ident: b0360 article-title: Fecal metabolic profiling of breast cancer patients during neoadjuvant chemotherapy reveals potential biomarkers publication-title: Molecules – volume: 62 start-page: 1178 year: 2019 end-page: 1193 ident: b0165 article-title: Alterations in intestinal microbiota of colorectal cancer patients receiving radical surgery combined with adjuvant CapeOx therapy publication-title: Sci China Life Sci – volume: 21 start-page: 178 year: 2023 ident: b0315 article-title: Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis publication-title: BMC Med – volume: 29 start-page: 2973 year: 2022 end-page: 2994 ident: b0060 article-title: The chemo-gut pilot study: associations between gut microbiota, gastrointestinal symptoms, and psychosocial health outcomes in a cross-sectional sample of young adult cancer survivors publication-title: Current Oncology – volume: 33 start-page: 1039 year: 2003 end-page: 1050 ident: b0055 article-title: Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer’s disease publication-title: Psychol Med – volume: 12 start-page: 2135 year: 2022 ident: b0340 article-title: Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis publication-title: Sci Rep – volume: 11 start-page: 506 year: 2014 end-page: 514 ident: b0115 article-title: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic publication-title: Nat Rev Gastroenterol Hepatol – volume: 17 start-page: 7618 year: 2020 ident: b0010 article-title: The Gut Microbiota and Inflammation: An Overview publication-title: Int J Environ Res Public Health – volume: 11 year: 2021 ident: b0230 article-title: Emerging evidence of the gut microbiome in chemotherapy: a clinical review publication-title: Front Oncol – volume: 116 start-page: 3348 year: 2010 end-page: 3356 ident: b0325 article-title: Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer publication-title: Cancer – volume: 301 start-page: 74 year: 2016 end-page: 82 ident: b0190 article-title: Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer publication-title: J Neuroimmunol – reference: . – volume: 19 start-page: 203 year: 2004 end-page: 214 ident: b0290 article-title: Trail Making Test A and B: Normative data stratified by age and education publication-title: Archives of Clinical Neuropsychology – start-page: 134 year: 1985 end-page: 160 ident: b0255 article-title: The Halstead-Reitan Neuropsychological Test Battery: Therapy and clinical interpretation publication-title: The Neuropsychology Handbook: Behavioral and Clinical Perspectives – reference: Rudzki, L., Maes, M., 2020. The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major Depression. Molecular Neurobiology 2020 57:10 57, 4269–4295. – reference: Benton, A.L., Hamsher, K., 1976. Multilingual aphasia examination (2nd ed.). AJA Associates. – volume: 26 start-page: 706 year: 2012 end-page: 713 ident: b0180 article-title: Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy publication-title: Brain Behav Immun – volume: 6 start-page: 92 year: 2018 ident: b0245 article-title: Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies publication-title: Microbiome – reference: Tumour Microenvironment. pp. 173–215. – volume: 85 start-page: 186 year: 2020 end-page: 191 ident: b0235 article-title: Impact of chemotherapy on the association between fear of cancer recurrence and the gut microbiota in breast cancer survivors publication-title: Brain Behav Immun – volume: 19 start-page: 165 year: 2019 end-page: 177 ident: b0200 article-title: The global and regional survival rate of women with breast cancer: a systematic review and meta-analysis publication-title: Clin Breast Cancer – volume: 12 start-page: 43 year: 1998 ident: 10.1016/j.bbi.2024.05.039_b0015 article-title: Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest Reliability publication-title: Clin Neuropsychol doi: 10.1076/clin.12.1.43.1726 – volume: 19 start-page: 203 year: 2004 ident: 10.1016/j.bbi.2024.05.039_b0290 article-title: Trail Making Test A and B: Normative data stratified by age and education publication-title: Archives of Clinical Neuropsychology doi: 10.1016/S0887-6177(03)00039-8 – volume: 62 start-page: 1178 year: 2019 ident: 10.1016/j.bbi.2024.05.039_b0165 article-title: Alterations in intestinal microbiota of colorectal cancer patients receiving radical surgery combined with adjuvant CapeOx therapy publication-title: Sci China Life Sci doi: 10.1007/s11427-018-9456-x – volume: 15 start-page: 13 year: 2008 ident: 10.1016/j.bbi.2024.05.039_b0305 article-title: Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4402255 – volume: 26 start-page: 955 year: 2004 ident: 10.1016/j.bbi.2024.05.039_b0035 article-title: Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen publication-title: J Clin Exp Neuropsychol doi: 10.1080/13803390490510905 – volume: 124 year: 2018 ident: 10.1016/j.bbi.2024.05.039_b0145 article-title: Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities publication-title: Cancer doi: 10.1002/cncr.31584 – volume: 19 start-page: 165 year: 2019 ident: 10.1016/j.bbi.2024.05.039_b0200 article-title: The global and regional survival rate of women with breast cancer: a systematic review and meta-analysis publication-title: Clin Breast Cancer doi: 10.1016/j.clbc.2019.01.006 – volume: 11 start-page: 506 year: 2014 ident: 10.1016/j.bbi.2024.05.039_b0115 article-title: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2014.66 – volume: 6 start-page: 92 year: 2018 ident: 10.1016/j.bbi.2024.05.039_b0245 article-title: Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies publication-title: Microbiome doi: 10.1186/s40168-018-0483-7 – volume: 17 start-page: 7618 year: 2020 ident: 10.1016/j.bbi.2024.05.039_b0010 article-title: The Gut Microbiota and Inflammation: An Overview publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph17207618 – volume: 30 start-page: 1080 year: 2012 ident: 10.1016/j.bbi.2024.05.039_b0170 article-title: Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy publication-title: Journal of Clinical Oncology doi: 10.1200/JCO.2011.37.0189 – volume: 362 year: 2022 ident: 10.1016/j.bbi.2024.05.039_b0130 article-title: Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2021.577769 – year: 1997 ident: 10.1016/j.bbi.2024.05.039_b0320 – ident: 10.1016/j.bbi.2024.05.039_b0260 doi: 10.1007/s12035-020-01961-y – volume: 14 start-page: 3959 year: 2022 ident: 10.1016/j.bbi.2024.05.039_b0355 article-title: Altered Gut Microbiota and Its Clinical Relevance in Mild Cognitive Impairment and Alzheimer’s Disease: Shanghai Aging Study and Shanghai Memory Study publication-title: Nutrients doi: 10.3390/nu14193959 – volume: 9 year: 2019 ident: 10.1016/j.bbi.2024.05.039_b0185 article-title: Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice publication-title: Sci Rep doi: 10.1038/s41598-019-52893-0 – volume: 35 start-page: 699 year: 2023 ident: 10.1016/j.bbi.2024.05.039_b0300 article-title: Remote testing in Abbiategrasso (RTA): results from a counterbalanced cross-over study on direct-to-home neuropsychology with older adults publication-title: Aging Clin Exp Res doi: 10.1007/s40520-023-02343-9 – volume: 6 year: 2022 ident: 10.1016/j.bbi.2024.05.039_b0030 article-title: Acute and chronic effects of adjuvant therapy on inflammatory markers in breast cancer patients publication-title: JNCI Cancer Spectr doi: 10.1093/jncics/pkac052 – volume: 11 start-page: 1789 year: 2023 ident: 10.1016/j.bbi.2024.05.039_b0100 article-title: Characteristics of intestinal microbiota in japanese patients with mild cognitive impairment and a risk-estimating method for the disorder publication-title: Biomedicines doi: 10.3390/biomedicines11071789 – volume: 12 start-page: 703 year: 2011 ident: 10.1016/j.bbi.2024.05.039_b0335 article-title: International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer publication-title: Lancet Oncol doi: 10.1016/S1470-2045(10)70294-1 – volume: 33 start-page: 382 year: 2021 ident: 10.1016/j.bbi.2024.05.039_b0275 article-title: Technology meets tradition: a hybrid model for implementing digital tools in neuropsychology publication-title: International Review of Psychiatry doi: 10.1080/09540261.2020.1835839 – volume: 7 start-page: e39743 year: 2012 ident: 10.1016/j.bbi.2024.05.039_b0050 article-title: Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer publication-title: PLoS One doi: 10.1371/journal.pone.0039743 – volume: 21 start-page: 178 year: 2023 ident: 10.1016/j.bbi.2024.05.039_b0315 article-title: Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis publication-title: BMC Med doi: 10.1186/s12916-023-02751-8 – volume: 73 start-page: 439 year: 2022 ident: 10.1016/j.bbi.2024.05.039_b0215 article-title: The Gut-Brain Axis publication-title: Annu Rev Med doi: 10.1146/annurev-med-042320-014032 – volume: 25 start-page: 94 year: 2004 ident: 10.1016/j.bbi.2024.05.039_b0250 article-title: Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy publication-title: Cytokine doi: 10.1016/j.cyto.2003.10.004 – volume: 201 start-page: 139 year: 2023 ident: 10.1016/j.bbi.2024.05.039_b0105 article-title: Validating the PROMIS cognitive function short form in cancer survivors publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-023-06968-2 – volume: 13 start-page: 660 year: 2011 ident: 10.1016/j.bbi.2024.05.039_b0330 article-title: Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab publication-title: Neuro Oncol doi: 10.1093/neuonc/nor024 – volume: 59 start-page: 12 year: 1991 ident: 10.1016/j.bbi.2024.05.039_b0120 article-title: Clinical significance: A statistical approach to defining meaningful change in psychotherapy research publication-title: J Consult Clin Psychol doi: 10.1037/0022-006X.59.1.12 – volume: 57 year: 2022 ident: 10.1016/j.bbi.2024.05.039_b0160 article-title: Association of chemotherapy and subjective cognitive impairment in breast cancer patients: Meta-analysis of longitudinal prospective cohort studies publication-title: European Journal of Oncology Nursing doi: 10.1016/j.ejon.2022.102099 – ident: 10.1016/j.bbi.2024.05.039_b0095 doi: 10.1136/bmj.m4087 – ident: 10.1016/j.bbi.2024.05.039_b0075 doi: 10.1007/978-3-030-20301-6_9 – volume: 53 start-page: 983 year: 1997 ident: 10.1016/j.bbi.2024.05.039_b0155 article-title: Small sample inference for fixed effects from restricted maximum likelihood publication-title: Biometrics doi: 10.2307/2533558 – volume: 12 start-page: 178 year: 2018 ident: 10.1016/j.bbi.2024.05.039_b0065 article-title: Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy publication-title: Journal of Cancer Survivorship doi: 10.1007/s11764-017-0656-6 – volume: 26 start-page: 706 year: 2012 ident: 10.1016/j.bbi.2024.05.039_b0180 article-title: Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2012.02.001 – volume: 26 year: 2021 ident: 10.1016/j.bbi.2024.05.039_b0360 article-title: Fecal metabolic profiling of breast cancer patients during neoadjuvant chemotherapy reveals potential biomarkers publication-title: Molecules doi: 10.3390/molecules26082266 – volume: 36 start-page: 3231 year: 2018 ident: 10.1016/j.bbi.2024.05.039_b0125 article-title: Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study publication-title: Journal of Clinical Oncology doi: 10.1200/JCO.2018.78.6624 – volume: 116 start-page: 470 year: 2020 ident: 10.1016/j.bbi.2024.05.039_b0285 article-title: The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2020.07.002 – volume: 13 start-page: 526 year: 2023 ident: 10.1016/j.bbi.2024.05.039_b0270 article-title: Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria publication-title: Sci Rep doi: 10.1038/s41598-023-27436-3 – volume: 32 start-page: 1298 year: 2023 ident: 10.1016/j.bbi.2024.05.039_b0310 article-title: Subjective cognition and memory lapses in the daily lives of breast cancer survivors: Examining associations with objective cognitive performance, fatigue, and depressed mood publication-title: Psychooncology doi: 10.1002/pon.6185 – volume: 12 start-page: 2135 year: 2022 ident: 10.1016/j.bbi.2024.05.039_b0340 article-title: Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis publication-title: Sci Rep doi: 10.1038/s41598-022-05682-1 – ident: 10.1016/j.bbi.2024.05.039_b0040 – volume: 116 start-page: 3348 year: 2010 ident: 10.1016/j.bbi.2024.05.039_b0325 article-title: Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer publication-title: Cancer doi: 10.1002/cncr.25098 – ident: 10.1016/j.bbi.2024.05.039_b0020 – volume: 2021 year: 2021 ident: 10.1016/j.bbi.2024.05.039_b0195 article-title: Kai-Xin-San Attenuates doxorubicin-induced cognitive impairment by reducing inflammation, oxidative stress, and neural degeneration in 4T1 breast cancer mice publication-title: Evid Based Complement Alternat Med doi: 10.1155/2021/5521739 – volume: 95 start-page: 401 year: 2021 ident: 10.1016/j.bbi.2024.05.039_b0085 article-title: Manipulations of the gut microbiome alter chemotherapy-induced inflammation and behavioral side effects in female mice publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2021.04.014 – volume: 28 start-page: 997 year: 2019 ident: 10.1016/j.bbi.2024.05.039_b0090 article-title: Relationship of fatigue with cognitive performance in women with early-stage breast cancer over 2 years publication-title: Psychooncology doi: 10.1002/pon.5028 – volume: 301 start-page: 74 year: 2016 ident: 10.1016/j.bbi.2024.05.039_b0190 article-title: Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2016.11.002 – volume: 11 year: 2021 ident: 10.1016/j.bbi.2024.05.039_b0230 article-title: Emerging evidence of the gut microbiome in chemotherapy: a clinical review publication-title: Front Oncol doi: 10.3389/fonc.2021.706331 – volume: 6 year: 2020 ident: 10.1016/j.bbi.2024.05.039_b0205 article-title: Estimation of US patients with cancer who may respond to cytotoxic chemotherapy publication-title: Future Sci OA doi: 10.2144/fsoa-2020-0024 – volume: 10 start-page: 2719 year: 2019 ident: 10.1016/j.bbi.2024.05.039_b0225 article-title: Establishing microbial composition measurement standards with reference frames publication-title: Nat Commun doi: 10.1038/s41467-019-10656-5 – volume: 12 start-page: 19547 year: 2022 ident: 10.1016/j.bbi.2024.05.039_b0025 article-title: Impacts of breast cancer and chemotherapy on gut microbiome, cognitive functioning, and mood relative to healthy controls publication-title: Sci Rep doi: 10.1038/s41598-022-23793-7 – volume: 8 start-page: 1587 year: 2020 ident: 10.1016/j.bbi.2024.05.039_b0345 article-title: Gut Microbiota and Immune System Interactions publication-title: Microorganisms doi: 10.3390/microorganisms8101587 – volume: 18 start-page: 373 year: 2004 ident: 10.1016/j.bbi.2024.05.039_b0175 article-title: Normative data for determining significance of test-retest differences on eight common neuropsychological instruments publication-title: Clin Neuropsychol doi: 10.1080/1385404049052420 – start-page: 134 year: 1985 ident: 10.1016/j.bbi.2024.05.039_b0255 article-title: The Halstead-Reitan Neuropsychological Test Battery: Therapy and clinical interpretation – volume: 26 start-page: 1230 year: 2012 ident: 10.1016/j.bbi.2024.05.039_b0140 article-title: Symptom validity indicators embedded in the controlled oral word association test publication-title: Clin Neuropsychol doi: 10.1080/13854046.2012.709886 – volume: 161 start-page: 10 year: 2022 ident: 10.1016/j.bbi.2024.05.039_b0150 article-title: Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial publication-title: Eur J Cancer doi: 10.1016/j.ejca.2021.11.006 – volume: 71 start-page: 63 year: 2020 ident: 10.1016/j.bbi.2024.05.039_b0080 article-title: Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia publication-title: Clinical Infectious Diseases doi: 10.1093/cid/ciz777 – volume: 12 start-page: 3046 year: 2020 ident: 10.1016/j.bbi.2024.05.039_b0350 article-title: Changes in plasma IL-1β, TNF-α and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients publication-title: Am J Transl Res – volume: 158 start-page: 1000 year: 2014 ident: 10.1016/j.bbi.2024.05.039_b0240 article-title: Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease publication-title: Cell doi: 10.1016/j.cell.2014.08.006 – volume: 14 start-page: 167 year: 1999 ident: 10.1016/j.bbi.2024.05.039_b0295 article-title: Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming publication-title: Arch Clin Neuropsychol – volume: 19 start-page: 83 year: 2005 ident: 10.1016/j.bbi.2024.05.039_b0070 article-title: Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea publication-title: Canadian Journal of Gastroenterology doi: 10.1155/2005/618504 – volume: 42 start-page: 515 year: 2015 ident: 10.1016/j.bbi.2024.05.039_b0220 article-title: Chemotherapy-driven dysbiosis in the intestinal microbiome publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13302 – volume: 29 start-page: 2973 year: 2022 ident: 10.1016/j.bbi.2024.05.039_b0060 article-title: The chemo-gut pilot study: associations between gut microbiota, gastrointestinal symptoms, and psychosocial health outcomes in a cross-sectional sample of young adult cancer survivors publication-title: Current Oncology doi: 10.3390/curroncol29050243 – volume: 35 start-page: 1913 year: 2017 ident: 10.1016/j.bbi.2024.05.039_b0135 article-title: United states population-based estimates of patient-reported outcomes measurement information system symptom and functional status reference values for individuals with cancer publication-title: Journal of Clinical Oncology doi: 10.1200/JCO.2016.71.4410 – volume: 85 start-page: 186 year: 2020 ident: 10.1016/j.bbi.2024.05.039_b0235 article-title: Impact of chemotherapy on the association between fear of cancer recurrence and the gut microbiota in breast cancer survivors publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2019.02.025 – volume: 8 start-page: 89 year: 2022 ident: 10.1016/j.bbi.2024.05.039_b0005 article-title: Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy publication-title: NPJ Breast Cancer doi: 10.1038/s41523-022-00455-5 – volume: 33 start-page: 1039 year: 2003 ident: 10.1016/j.bbi.2024.05.039_b0055 article-title: Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer’s disease publication-title: Psychol Med doi: 10.1017/S0033291703008031 – volume: 11 start-page: 329 year: 1996 ident: 10.1016/j.bbi.2024.05.039_b0265 article-title: Benton controlled oral word association test: Reliability and updated norms publication-title: Archives of Clinical Neuropsychology doi: 10.1093/arclin/11.4.329 – volume: 10 year: 2024 ident: 10.1016/j.bbi.2024.05.039_b0210 article-title: On the limits of 16S rRNA gene-based metagenome prediction and functional profiling publication-title: Microb Genom – volume: 164 start-page: 179 year: 2017 ident: 10.1016/j.bbi.2024.05.039_b0045 article-title: Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-017-4240-6 – volume: 14 year: 2022 ident: 10.1016/j.bbi.2024.05.039_b0110 article-title: Facilitating a high-quality dietary pattern induces shared microbial responses linking diet quality, blood pressure, and microbial sterol metabolism in caregiver-child dyads publication-title: Gut Microbes doi: 10.1080/19490976.2022.2150502 – volume: 80 start-page: 44 year: 2019 ident: 10.1016/j.bbi.2024.05.039_b0280 article-title: Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2019.02.020 |
| SSID | ssj0005318 |
| Score | 2.481103 |
| Snippet | •Chemotherapy induces microbiome disruption, inflammation, and cognitive decline.•The resulting microbiome disruption relates to cognitive decline and... Chemotherapy is notorious for causing behavioral side effects (e.g., cognitive decline). Notably, the gut microbiome has recently been reported to communicate... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 208 |
| SubjectTerms | Adult Aged Antineoplastic Agents - adverse effects Breast Neoplasms - drug therapy Cognition - drug effects Cognitive Dysfunction - chemically induced Cognitive Dysfunction - microbiology Cognitive impairment Cytokines Cytokines - blood Cytokines - metabolism Differential abundance analysis Feces - microbiology Female Gastrointestinal Microbiome - drug effects Humans Inflammation - microbiology Interleukin-6 - blood Interleukin-6 - metabolism Longitudinal Studies Microbial diversity Middle Aged Objective cognition Subjective cognition Tumor Necrosis Factor-alpha - blood Tumor Necrosis Factor-alpha - metabolism |
| Title | Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0889159124004392 https://dx.doi.org/10.1016/j.bbi.2024.05.039 https://www.ncbi.nlm.nih.gov/pubmed/38823430 https://www.proquest.com/docview/3063472010 |
| Volume | 120 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhhdJLaZM-to-gQumhxF3betg-LkvD9pFQ2gZyE3oGl64Tdr2HvfS3d0aWlxbaFHqyLSQsNKN5aL4ZEfLSA5ldqCUwr2MxzJjVhoWs1EWtKy_Axsd859MzuTjn7y_ExR6Zj7kwCKtMsn-Q6VFap5ZpWs3pddtOvyBAB5RxgShIUKsohzmvkMvf_PgF5jGc8UU0D_YeI5sR42VMCy5iyWPxTrwv_M-66W-2Z9RBJ_fI3WQ80tkwv_tkz3cH5HDWgeO83NJXNMI54zn5Abl9mqLmh2SLVQFSptU2AyccyOno5aany3aow7T01LXr1SbKj2MKXAeMMiQ1HlPdObpDGVHnMZnSQx8a_BLUC02lWdcUz3SpQZR7Ty1y0-oBOT95-3W-yNKVC5nlOeuzxjR1YbUNBQvWSddoAS-8zoUN0GBl6YsAC25FYWG7W9kIp0MJRp0w0MGyh2S_u-r8Y0I9r4KUlTFg03EpdROkLXXuSuGsr5ifkHxcbGVTPXK8FuO7GoFn3xTQRyF9VC4U0GdCXu-GXA_FOG7qXI4UVGOWKchFBaripkF8N-g3NvzXsBcjiyjYnhhz0Z2_2qwVeGSMVwg5mJBHA-_sps7Au2Gc5U_-76dPyR38GtCIz8h-v9r452Ah9eYoboEjcms2__zxEz7ffVic_QQjYxJ4 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7CBtpeSpv0selLhdJDiVnbetg-LqFh02T30gRyE7IewaXrhF3vYf99RrK8pdCm0JuRNdhoRvPQfDMC-GSRzcaVAoXX0JBmTMqauiRXWakKy9HH9_XO84WYXbFv1_x6D06GWhgPq4y6v9fpQVvHkUlczcld00y-e4AOGuPMoyDRrKIe3vfdqfgI9qdn57PFL6RHf8wXAD2eYEhuBphXXTcYJeYs9O_0V4b_2Tz9zf0MZuj0GTyN_iOZ9r_4HPZsewCH0xZj5-WWfCYB0RmOyg_g0Twmzg9h6xsDxGKrbYJxOHLUkJtNR5ZN34ppaYlp1qtNUCHHBAUPZaWvazwmqjVkBzQixvp6SotziLNLtDAkdmddE3-sS2oPdO-I9gK1egFXp18vT2ZJvHUh0SylXVLVVZlppV1GnTbCVIrjAytTrh0OaJHbzOGaa55p3PFaVNwol6Nfx2ucoOlLGLW3rX0NxLLCCVHUNbp1TAhVOaFzlZqcG20LaseQDostdWxJ7m_G-CkH7NkPifyRnj8y5RL5M4YvO5K7vh_HQ5PzgYNyKDRF1SjRWjxExHZEv0niv8g-DiIicYf6tItq7e1mLTEoo6zwqIMxvOplZ_frFAMcymh69H8f_QCPZ5fzC3lxtjh_A0_8mx6c-BZG3Wpj36HD1NXv44a4B-CXE5Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chemotherapy-induced+gut+microbiome+disruption%2C+inflammation%2C+and+cognitive+decline+in+female+patients+with+breast+cancer&rft.jtitle=Brain%2C+behavior%2C+and+immunity&rft.au=Otto-Dobos%2C+L+D&rft.au=Grant%2C+C+V&rft.au=Lahoud%2C+A+A&rft.au=Wilcox%2C+O+R&rft.date=2024-08-01&rft.eissn=1090-2139&rft.volume=120&rft.spage=208&rft_id=info:doi/10.1016%2Fj.bbi.2024.05.039&rft_id=info%3Apmid%2F38823430&rft.externalDocID=38823430 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0889-1591&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0889-1591&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0889-1591&client=summon |